PD5K3

· Chongqing Peg-Bio Biopharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PD5K3, covering 2024-07-30 to 2024-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PD5K3 in Healthy Adult Volunteers [Phase 1]